{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:48:01Z","timestamp":1786650481459,"version":"build-2736575974"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pediatr Card"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0974-2069.132478","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T05:46:30Z","timestamp":1400046390000},"page":"107","source":"Crossref","is-referenced-by-count":75,"title":["Familial hypercholesterolemia: A review"],"prefix":"10.4103","volume":"7","author":[{"given":"MithunJ","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-2069.132478-1","first-page":"138","volume-title":"Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis.The Bogalusa Heart Study","author":"Newman","year":"1986","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-2","first-page":"331","volume-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"key":"key-10.4103\/0974-2069.132478-3","unstructured":"Fagge CH. Xanthomatous diseases of the skin. Trans Pathol Soc Lond 1873;242-50."},{"key":"key-10.4103\/0974-2069.132478-4","first-page":"675","volume-title":"Angina pectoris in hereditary xanthomatosis","author":"Muller","year":"1939","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0974-2069.132478-5","first-page":"5153","volume-title":"Binding and degradation of low density lipoproteins by cultured human fibroblasts.Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia","author":"Goldstein","year":"1974","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-2069.132478-6","first-page":"485","volume-title":"Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database","author":"Leigh","year":"2008","journal-title":"Ann Hum Genet"},{"key":"key-10.4103\/0974-2069.132478-7","first-page":"5","volume-title":"Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R","author":"Soufi","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"key-10.4103\/0974-2069.132478-8","unstructured":"Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Sly WS, Childs B, editors. The metabolic and molecular bases of inherited disease. 8 th ed. New York: McGraw-Hill, Medical Publishing Division; 2000. pp. 2863-913."},{"key":"key-10.4103\/0974-2069.132478-9","first-page":"413","volume-title":"Current management of severe homozygous hypercholesterolaemias","author":"Naoumova","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-10","first-page":"49","volume-title":"Familial hypercholesterolaemia","author":"Marais","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"key-10.4103\/0974-2069.132478-11","first-page":"S1","volume-title":"; National Lipid Association Expert Panel on Familial Hypercholesterolemia.Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-12","first-page":"2878","volume-title":"; American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group.Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: A scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group","author":"Arnett","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-13","first-page":"1795","volume-title":"Monogenic hypercholesterolemia: New insights in pathogenesis and treatment","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0974-2069.132478-14","first-page":"1264","volume-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-15","first-page":"841","volume-title":"Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: A clinical and molecular genetic analysis","author":"Arca","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.132478-16","first-page":"398","volume-title":"Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-17","first-page":"1293","volume-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.132478-18","first-page":"1546","volume-title":"Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile","author":"McGill","year":"2001","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-19","first-page":"525","volume-title":"National Cholesterol Education Program: Report of the expert panel on blood cholesterol levels in children and adolescents","author":"American","year":"1992","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.132478-20","first-page":"198","volume-title":"Lipid screening and cardiovascular health in childhood","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.132478-21","first-page":"253","volume-title":"High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease - the GENECARD project","author":"Hurrell","year":"2007","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-22","first-page":"122","volume-title":"Screening for familial hypercholesterolaemia","author":"Bender","year":"2012","journal-title":"Pathology"},{"key":"key-10.4103\/0974-2069.132478-23","first-page":"S213","volume-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report","author":"Expert","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.132478-24","first-page":"S30","volume-title":"Pediatric aspects of familial hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-25","first-page":"423","volume-title":"Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: Importance of genetic testing in the entire family","author":"Garcia-Garcia","year":"2011","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-26","unstructured":"DeMott K, Nherera L, Shaw EJ, Minhas R, Humphries SE, Kathoria M, et al. Clinical Guidelines and Evidence Review for Familial hypercholesterolaemia: The identification and management of adults and children with familial hypercholesterolaemia. 2008. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners."},{"key":"key-10.4103\/0974-2069.132478-27","first-page":"572","volume-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","author":"Taylor","year":"2010","journal-title":"Clin Genet"},{"key":"key-10.4103\/0974-2069.132478-28","first-page":"630","volume-title":"Redefining normal low-density lipoprotein cholesterol: A strategy to unseat coronary disease as the nation\u2032s leading killer","author":"Forrester","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0974-2069.132478-29","first-page":"3332","volume-title":"Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia","author":"Vuorio","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/0974-2069.132478-30","first-page":"27","volume-title":"Lipid and lipoprotein distributions in white children ages 6-19 yr.The Lipid Research Clinics Program Prevalence Study","author":"Tamir","year":"1981","journal-title":"J Chronic Dis"},{"key":"key-10.4103\/0974-2069.132478-31","first-page":"879","volume-title":"Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey","author":"Hickman","year":"1998","journal-title":"Prev Med"},{"key":"key-10.4103\/0974-2069.132478-32","first-page":"a1095","volume-title":"Familial hypercholesterolaemia: Summary of NICE guidance","author":"Wierzbicki","year":"2008","journal-title":"BMJ"},{"key":"key-10.4103\/0974-2069.132478-33","first-page":"272","volume-title":"Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-34","unstructured":"Schaefer EJ, Santos RD. Xanthomatoses and Lipoprotein Disorders. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Dermatology in general medicine. McGraw-Hill Professional; 2012. p. 1601."},{"key":"key-10.4103\/0974-2069.132478-35","first-page":"439","volume-title":"Hypercholesterolemic valvulopathy: An aspect of malignant atherosclerosis","author":"Kawaguchi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"key-10.4103\/0974-2069.132478-36","first-page":"171","volume-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0974-2069.132478-37","first-page":"55","volume-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-38","first-page":"893","volume-title":"Scientific Steering Committee on behalf of the Simon Broome Register Group","author":"Risk","year":"1991","journal-title":"BMJ"},{"key":"key-10.4103\/0974-2069.132478-39","first-page":"189","volume-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large cross-sectional study in The Netherlands","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-40","first-page":"256","volume-title":"Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: Seven-year results of the Dietary Intervention Study in Children (DISC)","author":"Obarzanek","year":"2001","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.132478-41","doi-asserted-by":"crossref","unstructured":"Shafiq N, Singh M, Kaur S, Khosla P, Malhotra S. Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst Rev 2010;CD001918.","DOI":"10.1002\/14651858.CD001918.pub2"},{"key":"key-10.4103\/0974-2069.132478-42","first-page":"127","volume-title":"Primary hyperlipidemias in children: Effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption","author":"Guardamagna","year":"2011","journal-title":"Acta Diabetol"},{"key":"key-10.4103\/0974-2069.132478-43","first-page":"255","volume-title":"Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject","author":"Ketomaki","year":"2004","journal-title":"J Lab Clin Med"},{"key":"key-10.4103\/0974-2069.132478-44","first-page":"1612","volume-title":"Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread","author":"Amundsen","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"key-10.4103\/0974-2069.132478-45","first-page":"76","volume-title":"A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia","author":"Davidson","year":"2011","journal-title":"J Clin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-46","first-page":"1948","volume-title":"; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing.Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-47","doi-asserted-by":"crossref","unstructured":"Stein EA, Marais AD, Szamosi T, Raal FJ, Schurr D, Urbina EM, et al. Colesevelam hydrochloride: Efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr 2010;156: 231-6.e1-3.","DOI":"10.1016\/j.jpeds.2009.08.037"},{"key":"key-10.4103\/0974-2069.132478-48","first-page":"485","volume-title":"Evaluation and management of hyperlipidemia in children and adolescents","author":"Iughetti","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"key-10.4103\/0974-2069.132478-49","first-page":"1309","volume-title":"Storm over statins - the controversy surrounding pharmacologic treatment of children","author":"de","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-50","doi-asserted-by":"crossref","unstructured":"Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev 2010;CD006401.","DOI":"10.1002\/14651858.CD006401.pub2"},{"key":"key-10.4103\/0974-2069.132478-51","first-page":"482","volume-title":"Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: Evaluation of cholesterol changes and side effects","author":"O\u2032Gorman","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"key-10.4103\/0974-2069.132478-52","first-page":"339","volume-title":"Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis","author":"Arambepola","year":"2007","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-53","first-page":"267","volume-title":"Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: Efficacy and tolerability","author":"Carreau","year":"2011","journal-title":"Paediatr Drugs"},{"key":"key-10.4103\/0974-2069.132478-54","first-page":"e1053","volume-title":"Trends in the prevalence of chronic medication use in children: 2002-2005","author":"Cox","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.132478-55","first-page":"1201","volume-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"key-10.4103\/0974-2069.132478-56","first-page":"869","volume-title":"Ezetimibe treatment of pediatric patients with hypercholesterolemia","author":"Clauss","year":"2009","journal-title":"J Pediatr"},{"key":"key-10.4103\/0974-2069.132478-57","first-page":"2469","volume-title":"Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia","author":"Gagn\u00e9","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-58","first-page":"1421","volume-title":"Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia","author":"van","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0974-2069.132478-59","first-page":"1431","volume-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-60","first-page":"1343","volume-title":"; SEAS Investigators.Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-61","first-page":"2283","volume-title":"Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: Results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease","author":"Stein","year":"2012","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-62","first-page":"998","volume-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebo-controlled trial","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.132478-63","first-page":"1108","volume-title":"Effect of a monoclonal antibody to PCSK9 on LDL cholesterol","author":"Stein","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-64","first-page":"763","volume-title":"Antisense inhibition of proprotein convertase subtilisin\/kexin type 9 reduces serum LDL in hyperlipidemic mice","author":"Graham","year":"2007","journal-title":"J Lipid Res"},{"key":"key-10.4103\/0974-2069.132478-65","first-page":"527","volume-title":"Familial hypercholesterolemia: Present and future management","author":"Sjouke","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"key-10.4103\/0974-2069.132478-66","first-page":"1891","volume-title":"Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia","author":"Roth","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-67","first-page":"148","volume-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-68","unstructured":"FDA Approves Aegerion Pharmaceuticals\u2032 JUXTAPID(TM) (lomitapide) Capsules for Homozygous Familial Hypercholesterolemia (HoFH) (NASDAQ:AEGR) [Internet]. Available from: http:\/\/ir.aegerion.com\/releasedetail.cfm?ReleaseID=728650 [Last cited on 2013 May 29];"},{"key":"key-10.4103\/0974-2069.132478-69","first-page":"40","volume-title":"; Phase 3 HoFH Lomitapide Study investigators.Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.132478-70","first-page":"906","volume-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.132478-71","first-page":"1084","volume-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","author":"Shaw","year":"2008","journal-title":"Circ Res"},{"key":"key-10.4103\/0974-2069.132478-72","first-page":"247","volume-title":"Recommendations for the use of LDL apheresis","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-73","first-page":"279","volume-title":"Low-density lipoprotein apheresis as a treatment option for hyperlipidemia","author":"Mehta","year":"2009","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"key-10.4103\/0974-2069.132478-74","first-page":"363","volume-title":"Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia","author":"Lee","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"key-10.4103\/0974-2069.132478-75","first-page":"487","volume-title":"Lipoprotein apheresis","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-76","first-page":"519","volume-title":"The rebound of lipoproteins after LDL-apheresis.Kinetics and estimation of mean lipoprotein levels","author":"Kroon","year":"2000","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-77","first-page":"1489","volume-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia.Hokuriku-FH-LDL-Apheresis Study Group","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0974-2069.132478-78","first-page":"220","volume-title":"Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: The Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART)","author":"Matsuzaki","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0974-2069.132478-79","first-page":"492","volume-title":"Severe hypercholesterolaemia: Therapeutic goals and eligibility criteria for LDL apheresis in Europe","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"key-10.4103\/0974-2069.132478-80","first-page":"517","volume-title":"Virus treatment questioned after gene therapy death","author":"Lehrman","year":"1999","journal-title":"Nature"},{"key":"key-10.4103\/0974-2069.132478-81","first-page":"36","volume-title":"LDLR-Gene therapy for familial hypercholesterolaemia: Problems, progress, and perspectives","author":"Al-Allaf","year":"2010","journal-title":"Int Arch Med"},{"key":"key-10.4103\/0974-2069.132478-82","first-page":"E25","volume-title":"Preemptive liver transplantation in a child with familial hypercholesterolemia","author":"Maiorana","year":"2011","journal-title":"Pediatr Transplant"},{"key":"key-10.4103\/0974-2069.132478-83","first-page":"281","volume-title":"Liver transplantation as a treatment option for three siblings with homozygous familial hypercholesterolemia","author":"K\u00fc\u00e7\u00fckkartallar","year":"2011","journal-title":"Pediatr Transplant"},{"key":"key-10.4103\/0974-2069.132478-84","first-page":"20","volume-title":"Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients","author":"Sprecher","year":"1984","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0974-2069.132478-85","first-page":"262","volume-title":"Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0974-2069.132478-86","first-page":"731","volume-title":"Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia","author":"Haitas","year":"1990","journal-title":"Q J Med"},{"key":"key-10.4103\/0974-2069.132478-87","first-page":"2202","volume-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-88","first-page":"1380","volume-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.132478-89","first-page":"476","volume-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.132478-90","first-page":"2625","volume-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0974-2069.132478-91","first-page":"22","volume-title":"Risk of fatal stroke in patients with treated familial hypercholesterolemia: A prospective registry study","author":"Huxley","year":"2003","journal-title":"Stroke"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:19:08Z","timestamp":1786648748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-2069.132478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["132478"],"URL":"https:\/\/doi.org\/10.4103\/0974-2069.132478","relation":{},"ISSN":["0974-2069"],"issn-type":[{"value":"0974-2069","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}